gas with tirzepatide Side Effects: How Zepbound & Mounjaro Affect Digestion In a 36-year-old patient taking

Some of these patients developed serious, life-threatening medical issues affecting their gastrointestinal system that required surgery and other kinds of emergency treatment

Visible ice crystals signal that the medication should be discarded and replaced

10.1016/j.bbrc.2015.08.092 238

Biopharma companies face: Massive competition and potential market saturation with over 500 GLP-1-related clinical trials across 100+ indications Downward price pressure Highly restricted reimbursement and resistance to new indications Mechanism-based stratification can: Enrich clinical trials for responders (response biomarkers) Identify strong responder subgroups (complementary diagnostic) Differentiate competing assets Support development in new indications (biomarker-led indication switching) De-risk late-stage programs (clinical trial design) Previous efforts to expand GLP-1s into new indications - such as the semaglutide Alzheimers trial - largely targeted broad patient groups defined by their clinical symptoms or diagnostic labels